-
1دورية أكاديمية
المؤلفون: Boeder, Schafer, Edelman, Steven V
المصدر: Diabetes Obesity and Metabolism. 21(Suppl 2)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Clinical Trials and Supportive Activities, Pediatric, Diabetes, Patient Safety, Prevention, Clinical Research, Cardiovascular, Autoimmune Disease, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Metabolic and endocrine, Adult, Benzhydryl Compounds, Blood Glucose, Body Mass Index, Body Weight, Canagliflozin, Diabetes Mellitus, Type 1, Diabetic Ketoacidosis, Double-Blind Method, Drug Therapy, Combination, Female, Glucosides, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Sodium-Glucose Transporter 2 Inhibitors, Treatment Outcome, canagliflozin, dapagliflozin, empagliflozin, SGLT-2 inhibitor, type 1 diabetes, Endocrinology & Metabolism, Clinical sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/8sx858wsTest
-
2دورية أكاديمية
المؤلفون: Serrano Olave, Adriana, Bueno Moral, Ana Isabel, Martínez Bañón, Carmen, González Mesa, Ernesto, Jiménez López, Jesús S
مصطلحات موضوعية: SGLT-2 inhibitor, diabetes, emphysema, gangrene, gas, genital lump, surgery, Diabetes Mellitus, Type 2, Female, Fournier Gangrene, Glucose, Humans, Male, Sodium, Sodium-Glucose Transporter 2 Inhibitors
وصف الملف: application/pdf
العلاقة: http://hdl.handle.net/10668/21067Test; PMC9141785; https://www.mdpi.com/1660-4601/19/10/6261/pdf?version=1653114155Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141785/pdfTest
الإتاحة: https://doi.org/10.3390/ijerph19106261Test
http://hdl.handle.net/10668/21067Test
https://www.mdpi.com/1660-4601/19/10/6261/pdf?version=1653114155Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141785/pdfTest -
3
المؤلفون: Arne Gessner, Anna Gemeinhardt, Agnes Bosch, Dennis Kannenkeril, Christian Staerk, Andreas Mayr, Martin F. Fromm, Roland E. Schmieder, Renke Maas
المصدر: Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-11 (2022)
Cardiovascular Diabetologyمصطلحات موضوعية: Blood Glucose, Male, Time Factors, Endocrinology, Diabetes and Metabolism, Empagliflozin, Arginine, Double-Blind Method, Glucosides, Predictive Value of Tests, SDMA, Type 2 diabetes mellitus, Humans, Diseases of the circulatory (Cardiovascular) system, Prospective Studies, ddc:610, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Glycated Hemoglobin, Cross-Over Studies, Middle Aged, Dapagliflozin, Cardiovascular disease, Homoarginine, ADMA, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, SGLT-2 inhibitor, Female, Cardiology and Cardiovascular Medicine, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37197d9cf450acaf117361c0c553c9b4Test
https://doaj.org/article/84d0ad9359a24a469e3fdccbc5dcb7eaTest -
4
المؤلفون: Adriana Serrano Olave, Ana Isabel Bueno Moral, Carmen Martínez Bañón, Ernesto González Mesa, Jesús S. Jiménez López
المصدر: RIUMA. Repositorio Institucional de la Universidad de Málaga
instnameمصطلحات موضوعية: Male, diabetes, genital lump, Health, Toxicology and Mutagenesis, Sodium, Public Health, Environmental and Occupational Health, surgery, emphysema, Glucose, Diabetes Mellitus, Type 2, gas, SGLT-2 inhibitor, Humans, Female, gangrene, Sodium-Glucose Transporter 2 Inhibitors, Fournier Gangrene
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5c8b4de3a7e75ee572447c449886009Test
https://hdl.handle.net/10668/21067Test -
5
المؤلفون: Andrei Mircea Catarig, Jack Lawson, Abby Paine, Pierre Johansen, Robert D. Shaw, Matthew Capehorn, Anna Sandberg, Ildiko Lingvay
المصدر: The Journal of Clinical Endocrinology and Metabolism
مصطلحات موضوعية: Male, medicine.medical_specialty, endocrine system diseases, GLP-1 receptor agonist, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Glucagon-Like Peptides, Urology, Context (language use), Type 2 diabetes, individual patient data, Biochemistry, Endocrinology, Glucosides, Internal medicine, medicine, Empagliflozin, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Clinical Research Articles, Glucagon-like peptide 1 receptor, Glycated Hemoglobin, Clinical Trials as Topic, business.industry, Semaglutide, Biochemistry (medical), Middle Aged, medicine.disease, Metformin, Confidence interval, Treatment Outcome, indirect comparison, Diabetes Mellitus, Type 2, Meta-analysis, SGLT-2 inhibitor, Drug Therapy, Combination, Female, type 2 diabetes, business, AcademicSubjects/MED00250, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93797ecb6ab061afb7b205a599a86df1Test
https://doi.org/10.1210/clinem/dgaa577Test -
6
المؤلفون: Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
المساهمون: Giugliano, D., Longo, M., Scappaticcio, L., Bellastella, G., Maiorino, M. I., Esposito, K.
المصدر: Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)مصطلحات موضوعية: Male, Kidney Disease, Time Factors, Time Factor, Heart Diseases, Endocrinology, Diabetes and Metabolism, Risk Assessment, Type 2 diabete, Cardiovascular outcome trials, Diseases of the circulatory (Cardiovascular) system, Humans, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Aged, Clinical Trials as Topic, Sodium-Glucose Transporter 2 Inhibitor, Cardiorenal outcomes, SGLT-2 inhibitors, Cardiorenal outcome, Type 2 diabetes, Heart Disease Risk Factor, Middle Aged, Cardiovascular outcome trial, Heart Disease, Treatment Outcome, Diabetes Mellitus, Type 2, Heart Disease Risk Factors, RC666-701, SGLT-2 inhibitor, Female, Kidney Diseases, Cardiology and Cardiovascular Medicine, Human
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74ee06316808c9b8baa3d3f2ed4cdb48Test
http://europepmc.org/articles/PMC8680308Test -
7
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Eligibility Determination, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, cardiovascular disease, Internal medicine, Diabetes mellitus, Prevalence, Internal Medicine, Humans, Hypoglycemic Agents, Medicine, Generalizability theory, In patient, Registries, Sodium-Glucose Transporter 2 Inhibitors, Aged, business.industry, Atherosclerotic cardiovascular disease, Brief Report, Patient Selection, Middle Aged, Atherosclerosis, medicine.disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Brief Reports, observational study, Female, Observational study, type 2 diabetes, Trial Eligibility Criteria, business, Cardiovascular outcomes, SGLT‐2 inhibitor, Diabetic Angiopathies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b6d2e74ecc41dce2827e62b8029f5dTest
https://doi.org/10.1111/dom.13738Test -
8دورية أكاديمية
المؤلفون: Giugliano D., Longo M., Scappaticcio L., Bellastella G., Maiorino M. I., Esposito K.
المساهمون: Giugliano, D., Longo, M., Scappaticcio, L., Bellastella, G., Maiorino, M. I., Esposito, K.
مصطلحات موضوعية: Cardiorenal outcome, Cardiovascular outcome trial, SGLT-2 inhibitor, Type 2 diabete, Aged, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Female, Heart Disease Risk Factor, Heart Disease, Human, Kidney Disease, Male, Middle Aged, Risk Assessment, Sodium-Glucose Transporter 2 Inhibitor, Time Factor, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34915880; info:eu-repo/semantics/altIdentifier/wos/WOS:000730917200001; volume:20; issue:1; firstpage:236; journal:CARDIOVASCULAR DIABETOLOGY; http://hdl.handle.net/11591/467156Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121444043
-
9
المؤلفون: Haishan Wu, Xue-qing Yu, Xiaoyan Li, Ying Zhou, Jinjin Fan, Peiran Yin, Chaosheng Chen, Ning Luo, Chenfei Zheng
المصدر: Biomedicine & Pharmacotherapy, Vol 109, Iss, Pp 1327-1338 (2019)
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Glucose uptake, Empagliflozin, RM1-950, Peritoneal mesothelial cells, SGLT-2, Flow cytometry, Peritoneal dialysis, Rats, Sprague-Dawley, Excretion, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Sodium-Glucose Transporter 2, Peritoneum, Western blot, Dialysis Solutions, Internal medicine, medicine, Animals, Humans, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Cells, Cultured, Pharmacology, Hexokinase, medicine.diagnostic_test, Chemistry, General Medicine, Rats, Glucose, 030104 developmental biology, medicine.anatomical_structure, Endocrinology, 030220 oncology & carcinogenesis, SGLT-2 inhibitor, Female, Therapeutics. Pharmacology, Peritoneal Dialysis
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ae421768d3fe15b14259177de9d5faTest
https://doi.org/10.1016/j.biopha.2018.10.106Test -
10
المؤلفون: Oliver Schnell, Pieter Gillard, Per-Henrik Groop
المساهمون: Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, Diabetes Clinic, HUS Abdominal Center, Research Programs Unit, Department of Medicine, Per Henrik Groop / Principal Investigator, Clinicum, Nefrologian yksikkö, University of Helsinki, Helsinki University Hospital Area, CAMM - Research Program for Clinical and Molecular Metabolism
مصطلحات موضوعية: CHRONIC KIDNEY-DISEASE, Male, Diabetes Mellitus, Type 2/drug therapy, endocrine system diseases, medicine.medical_treatment, Endocrinology, Diabetes and Metabolism, DOUBLE-BLIND, 0302 clinical medicine, Endocrinology, Insulin, SGLT inhibition, Diabetic Nephropathies, 030212 general & internal medicine, Body mass index, METABOLIC SYNDROME, RISK, COMPLICATIONS, Diabetes, STAGE RENAL-DISEASE, GLOMERULAR HYPERFILTRATION, General Medicine, Kidney disease, Nephrology, Insulin/therapeutic use, Female, medicine.medical_specialty, Renal effects, Diabetes Mellitus, Type 1/drug therapy, Type 1 diabetes mellitus, Renal function, 030209 endocrinology & metabolism, Hypoglycemic Agents/therapeutic use, URIC-ACID, 03 medical and health sciences, Diabetes mellitus, Internal medicine, BASE-LINE CHARACTERISTICS, Internal Medicine, medicine, Hypoglycemic Agents, Humans, COTRANSPORTER 2 INHIBITORS, Diabetic kidney disease, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Type 1 diabetes, Renal Insufficiency, Chronic/drug therapy, business.industry, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, medicine.disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, 3121 General medicine, internal medicine and other clinical medicine, SGLT-2 inhibitor, Adjunctive treatment, Diabetic Nephropathies/drug therapy, Metabolic syndrome, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03aec7f8c17f21dae029eac6142bfa4cTest
https://biblio.vub.ac.be/vubir/the-nephrological-perspective-on-sglt2-inhibitors-in-type-1-diabetesTest(a44fea01-9080-41df-b6e2-d8cafdc8e82c).html